
Dasiglucagon, sold under the brand name Zegalogue, is a medication used to treat severe hypoglycemia in people with diabetes.
The most common side effects include nausea, vomiting, headache, diarrhea, and injection site pain.
Dasiglucagon was approved for medical use in the United States in March 2021.
Dasiglucagon is indicated for the treatment of severe hypoglycemia in people aged six years of age and older with diabetes.
×